New cream shows promise for treating lichen sclerosus in large trial
NCT ID NCT07335588
First seen Jan 14, 2026 · Last updated May 19, 2026 · Updated 19 times
Summary
This study tests a cream called delgocitinib for people with mild to severe lichen sclerosus, a skin condition that mainly affects the genital area. The trial includes 652 adults and lasts about a year, with twice-daily cream application. Researchers will check if the cream improves skin symptoms and reduces pain better than a placebo cream.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LICHEN SCLEROSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.